{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-097730","form_type":"8-K","ticker":"SCLX","cik":"0001820190","company_name":"Scilex Holding Co","filed_at":"2024-04-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:20.367356+00:00","generated_at":"2026-06-03T22:23:00.878556+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"medium","headline":"Scilex prelim Q1: ZTlido gross sales $34-38M (+24-38% YoY); net sales $12-13M (+13-23% YoY)","bullets":["ZTlido gross sales Q1 2024 estimated $34-38M vs $27.5M Q1 2023, up 24-38%.","ZTlido net sales Q1 2024 estimated $12-13M vs $10.6M Q1 2023, up 13-23%.","Company plans to cut R&D and admin expenses in 2024; focuses on late-stage pipeline like SP-102.","Change Healthcare co-pay processing for ZTlido restored to normal after cyber disruption."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-097730","json":"https://secwatch.observer/filing/0001193125-24-097730.json","markdown":"https://secwatch.observer/filing/0001193125-24-097730.md","text":"https://secwatch.observer/filing/0001193125-24-097730.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1820190/000119312524097730/0001193125-24-097730-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1820190/000119312524097730/d815788d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-03T22:23:00.878556+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"dedac3ae0d873455c1ec54ea2ab2fc0591f10940","claim":"Scilex Holding Co reported quarter ended March 31, 2024 results: revenue ZTlido gross sales for the first quarter of 2024 were in the range of $34.0 million to $38.0 million.","evidence_excerpt":"Scilex Holding Company (the “Company”) is providing certain preliminary unaudited financial results for the quarter ended March 31, 2024 based on currently available information.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1820190/000119312524097730/0001193125-24-097730-index.htm","confidence":0.85,"family_label":"Earnings Releases","details":[{"label":"Period","value":"quarter ended March 31, 2024"},{"label":"Revenue","value":"ZTlido gross sales for the first quarter of 2024 were in the range of $34.0 million to $38.0 million"},{"label":"Result","value":"preliminary results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}